Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy

ConditionHysteroscopy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorCairo University

About this trial

This study is conducted to assess whether the passive uterine straightening of the uterus by means of bladder filling is associated with less pain experienced by patients with excessive anteflexion of the uterus during office hysteroscopy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with excessive anteflexion of the uterus

Disqualifiers

Cervical pathology

Previous cervical surgery

Severe vaginal bleeding

Trial design

Design model

Parallel

Treatments tested in this trial

  • Empty bladder group

    Procedure/Surgery

    Patients in the empty bladder group will be instructed to empty the bladder immediately before the procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is empty. All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.

  • Bladder distension group

    Procedure/Surgery

    Patients in the bladder distension group will be instructed to drink one liter of water and to avoid urination during a period of 2 h before the scheduled procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is distended . All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Empty bladder groupActive comparator 1 intervention
Group B: Bladder distension groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Intensity of pain

Measured using 100 mm visual analogue scale ( 0 = no pain and 100 = worst possible pain)

Time frame
: Immediately after the procedure

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Bedaya Hospital

Collaborator